|
Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude
SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. Benchling AI agents in Claude handle the heavy-lifting of searching structured data like assay results and molecules and pulling unstructured context buried in lab notebooks, so scientists can focus on analysis and decisions.
jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE="
How scientists are using Benchling AI in Claude today. jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4', image: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4?p=thumbnail', autostart:'false', stretching : 'uniform', width: '512', height: '288'});
Building the AI ecosystem for biotech
AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few years," opening the door to far better prevention and treatment across diseases. Getting there requires operationalizing AI: pairing advanced models with trustworthy, secure data; purpose-built workflows; and access for every scientist.
"AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first," said Ashu Singhal, Co-founder and President of Benchling. "Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D."
"We're connecting Claude to the systems science already runs on. With Benchling's trusted data foundation and AI workflows, Claude helps teams move from research questions to results faster, at lab, program, and portfolio scale," said Eric Kauderer-Abrams, Head of Life Sciences and Biology, Anthropic.
What scientists can do today
Claude for Life Sciences leverages Benchling as the system of record while Claude synthesizes insights across the data. The integration between Claude and Benchling is possible via Model Context Protocol (MCP), and enables users to move seamlessly between the two, with one-click traceability to the underlying scientific data. Existing permissions and audit logs carry over automatically, so organizations can roll out AI across R&D while maintaining control and compliance.
Here's how researchers, program leads, bioinformaticians, and scientists are using Benchling in Claude.
| Category | Example prompt |
| Recommendations | "Based on our last three in vivo results in Benchling and recent FDA guidance, what should we test next?" |
| Portfolio insights | "Aggregate results from our top five programs and highlight which ones are showing the strongest early efficacy signals compared with industry benchmarks." |
| Workflow orchestration | "Pull my Benchling assay results and check for related compound data to see if we've already profiled these molecules." |
| Cross-source comparison | "Compare the IC50 results from my last two Benchling experiments with recent PubMed articles on AAV stability." |
| Multi-tool reporting | "Draft a report that combines Benchling notebook data with statistical analyses to create a single study summary." |
Access and availability
Benchling's AI agents in the Claude for Life Sciences ecosystem are available to Benchling customers with Benchling AI enabled. Customers should reach out to their account teams for set-up and more information.
About Benchling
Benchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups to global biopharmas like Merck, Moderna, and Sanofi. Benchling's products help scientists capture, connect, and analyze data across the R&D lifecycle. With Benchling AI, scientists use agents and models directly in their workflows, connected to structured data. The result: faster teams, better molecules, and breakthroughs for all.
About Anthropic
Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic's flagship product is Claude, a large language model trusted by millions of users worldwide. Anthropic's flagship product is Claude, a family of foundational AI models purpose-built for business tasks. Visit www.anthropic.com for more information.
Video - https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4
Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude
SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. Benchling AI agents in Claude handle the heavy-lifting of searching structured data like assay results and molecules and pulling unstructured context buried in lab notebooks, so scientists can focus on analysis and decisions.
How scientists are using Benchling AI in Claude today. jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4', image: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4?p=thumbnail', autostart:'false', stretching : 'uniform', width: '512', height: '288'});
Building the AI ecosystem for biotech
AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few years," opening the door to far better prevention and treatment across diseases. Getting there requires operationalizing AI: pairing advanced models with trustworthy, secure data; purpose-built workflows; and access for every scientist.
"AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first," said Ashu Singhal, Co-founder and President of Benchling. "Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D."
"We're connecting Claude to the systems science already runs on. With Benchling's trusted data foundation and AI workflows, Claude helps teams move from research questions to results faster, at lab, program, and portfolio scale," said Eric Kauderer-Abrams, Head of Life Sciences and Biology, Anthropic.
What scientists can do today
Claude for Life Sciences leverages Benchling as the system of record while Claude synthesizes insights across the data. The integration between Claude and Benchling is possible via Model Context Protocol (MCP), and enables users to move seamlessly between the two, with one-click traceability to the underlying scientific data. Existing permissions and audit logs carry over automatically, so organizations can roll out AI across R&D while maintaining control and compliance.
Here's how researchers, program leads, bioinformaticians, and scientists are using Benchling in Claude.
Category
Example prompt
Recommendations
"Based on our last three in vivo results in Benchling and recent FDA guidance, what should we test next?"
Portfolio insights
"Aggregate results from our top five programs and highlight which ones are showing the strongest early efficacy signals compared with industry benchmarks."
Workflow orchestration
"Pull my Benchling assay results and check for related compound data to see if we've already profiled these molecules."
Cross-source comparison
"Compare the IC50 results from my last two Benchling experiments with recent PubMed articles on AAV stability."
Multi-tool reporting
"Draft a report that combines Benchling notebook data with statistical analyses to create a single study summary."
Access and availability
Benchling's AI agents in the Claude for Life Sciences ecosystem are available to Benchling customers with Benchling AI enabled. Customers should reach out to their account teams for set-up and more information.
About Benchling
Benchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups to global biopharmas like Merck, Moderna, and Sanofi. Benchling's products help scientists capture, connect, and analyze data across the R&D lifecycle. With Benchling AI, scientists use agents and models directly in their workflows, connected to structured data. The result: faster teams, better molecules, and breakthroughs for all.
About Anthropic
Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic's flagship product is Claude, a large language model trusted by millions of users worldwide. Anthropic's flagship product is Claude, a family of foundational AI models purpose-built for business tasks. Visit www.anthropic.com for more information.
Video - https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Benchling Partners with Anthropic to Build a Bridge Between Science and AI
The Initiative Aims to Address the Pain Points of Family Filmmaking
BEIJING, Dec. 13, 2025 /PRNewswire/ -- On December 6th, the 3rd FamilyLens International Film Festival opened in Beijing. SmallRig, a global specialized provider of imaging solutions, collaborating with FamilyLens, is empowering family filmmaking through various initiatives, including the Family Filmmaking Co-Creation Initiative, a dedicated family filmmaking kit, and a social impact screening program.
Deepening the "Co-Creation Initiatives"
The Co-Creation Initiatives are a series of global creative initiatives open to filmmakers and image creators worldwide. Through deep collaboration across multiple dimensions — including product co-creation, discovery and promotion, and content co-creation — SmallRig aims to expand the boundaries of mobile filmmaking and bring the spirit of Free Your Dream to life with creators everywhere.
Following the launch of the Mobile Filmmaking Co-Creation Initiative at the 14th International Smartphone Film Festival, SmallRig announced the launch of the Family Filmmaking Co-Creation Initiative on December 6th at the 3rd FamilyLens International Film Festival. The initiative invites global creators and every family to participate, focusing on three core directions: product co-creation, work promotion, and content co-creation, to explore the possibilities of family filmmaking for everyone.
Mr. Zhou Yang, Founder and CEO of SmallRig, shared the inspiration for the initiative: "The initiative is rooted in the immense universality and profound emotional depth inherent in family narratives, which serve as a common emotional bond connecting global audiences. We firmly believe that in this era, where everyone can be a content creator, every family can and should film their own story. The instinct to create is deeply embedded in the human spirit, and every home is the origin of countless narratives."
Gu Xue, Founder and Director of the FamilyLens International Film Festival, stated: "We hope that people and practitioners around the world who care about family movies can find suitable solutions and gain insights from the Co-Creation Initiatives. We look forward to more and more people exploring the field of 'Home' together through this initiative."
To address the pain points of family filmmaking, SmallRig officially released the SmallRig Family Filmmaking Kit at the opening ceremony. The kit includes a high-quality microphone, fill light, and a portable tripod, specifically designed to achieve "professional function democratization" and "complex feature simplification." During the FamilyLens Workshop, attendees experienced the convenience of the equipment firsthand. Many expressed that the kit truly solves many problems, enabling ordinary families to complete necessary filming without specialized photography knowledge.
Social Impact Screening Program
The 3rd FamilyLens International Film Festival is open to the public from December 6th to 14th. The festival opened with the screening of well-received documentary: K-Family Affairs. In addition to the competition section, the festival features several distinctive sections, including the Reframing Home Movies— An Italian Retrospective, Youth Film Program, Filmmaker in Focus, and the Social Impact Program. Four major awards, such as the Real-Life Portrait Award and the Artistic Exploration Award, will also be presented.
As a key component of the Co-Creation Initiatives, the SmallRig Image Development Fund partnered with the FamilyLens International Film Festival to curate the "Social Impact Screening Program." This unit focuses on elevating awareness of critical issues within the family unit, advocating for a new reflection: "Starting with Seeing, Concluding with Understanding."
Arum Nam, Director of K-Family Affairs, stated:
"Starting with the stories of your family, your friends, and yourself, I believe this personal narrative can connect directly to the bigger society."
SmallRig believes that truly meaningful social impact storytelling stems from awareness in proximity—achieved by using the lens to penetrate the daily surface and enabling a deep, empathetic "Seeing with Empathy."
The four featured works in this unit are:
- People of the Ascent
- Granny's Lost and Found
- Ruixi at Fourteen
- No Country For My Maternal Grandma
These films highlight four family issues that require "seeing": the yearning of left-behind children, the mental isolation of Alzheimer's patients, the elderly searching for subjectivity in their drifting lives, and the emotional volatility and struggle of Bipolar Disorder.
Strategic Outlook and Future Expansion
SmallRig will continue to support the Family Filmmaking Co-Creation Initiative's deep development through promotional campaigns and practical workshops focused on family movie scenarios.
The overall goal of SmallRig's Global Co-creation Initiative is to continuously explore and meet the growing, diverse needs of global creators across different vertical domains. SmallRig is committed to persistently expanding the co-creation model into more imaging sectors, collaborating with industry partners to push the boundaries of imaging and grant global creators broader creative freedom.
About SmallRig
Founded in 2013, SmallRig is an innovation-driven global company that designs and manufactures comprehensive support solutions and accessories for all content creation needs. Trusted by over four million creators globally, SmallRig pioneered the User Co-creation Design (UCD) philosophy and the DreamRig Program.
For more information, visit: www.smallrig.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival
SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival
SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival
